REPLAGAL CONCENTRATE FOR SOLUTION FOR INFUSION 1 MG/ML
Product details
Registration number: SIN16197P
Classification: Prescription Only
Active ingredients: Agalsidase alfa
Strength: 1.0 mg/mL
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Registrant: TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.
ATC code: A16AB03
HSA approval date: 17 May 2021
Manufacturer(s):
- Vetter Pharma-Fertigung GmbH & Co. KG (bulk production and primary packager)
- Cangene bioPharma LLC (bulk production and primary packager)
Manufacturing country/countries: UNITED STATES; GERMANY
What are the HSA registration number and classification for REPLAGAL CONCENTRATE FOR SOLUTION FOR INFUSION 1 MG/ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16197P
Classification: Prescription Only
What active ingredients and strength are recorded for REPLAGAL CONCENTRATE FOR SOLUTION FOR INFUSION 1 MG/ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Agalsidase alfa
Strength: 1.0 mg/mL
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for REPLAGAL CONCENTRATE FOR SOLUTION FOR INFUSION 1 MG/ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for REPLAGAL CONCENTRATE FOR SOLUTION FOR INFUSION 1 MG/ML?
According to the HSA dataset updated 7 August 2026:
Registrant: TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD.
Which manufacturers and countries are listed for REPLAGAL CONCENTRATE FOR SOLUTION FOR INFUSION 1 MG/ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Vetter Pharma-Fertigung GmbH & Co. KG (bulk production and primary packager)
- Cangene bioPharma LLC (bulk production and primary packager)
Manufacturing country/countries: UNITED STATES; GERMANY
Where can I look up REPLAGAL CONCENTRATE FOR SOLUTION FOR INFUSION 1 MG/ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16197P or the exact product name REPLAGAL CONCENTRATE FOR SOLUTION FOR INFUSION 1 MG/ML. The general register link does not preselect this product.
What are the source dates for this REPLAGAL CONCENTRATE FOR SOLUTION FOR INFUSION 1 MG/ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this REPLAGAL CONCENTRATE FOR SOLUTION FOR INFUSION 1 MG/ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16197P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)